Physician profile
Ralph M Garrard
NPI 1063481083
$4,098.40
in general payments reported to CMS, 2019-2025
43 companies · $557 in 2025
The $557 reported for 2025 was more than what 83% of Obstetrics & Gynecology providers received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $755 · 2020: $263 · 2021: $158 · 2022: $951 · 2023: $808 · 2024: $607 · 2025: $557.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,846 · Education: $125.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,846.28 |
| Education | $125.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Radius Health, INC. | $506.93 | 2019-2025 | Tymlos |
| Abbvie INC. | $483.18 | 2019-2025 | |
| Astellas Pharma US INC | $371.45 | 2019-2025 | Veozah, Myrbetriq |
| Hologic Sales and Service, LLC | $331.58 | 2019-2025 | Aptima |
| Amgen INC. | $278.37 | 2019-2021 | |
| Mayne Pharma Commercial LLC | $164.84 | 2022-2025 | |
| Pfizer INC. | $162.81 | 2019-2024 | |
| Bayer Healthcare Pharmaceuticals INC. | $159.62 | 2022-2025 | |
| Sumitomo Pharma America, INC. | $154.32 | 2023-2024 | Myfembree, Gemtesa |
| Sage Therapeutics, LLC | $124.64 | 2023-2025 | Zurzuvae |
| Scynexis, INC. | $122.63 | 2022 | |
| Medical Device Business Services, INC. | $102.99 | 2021 | |
| Channel Medsystems, INC. | $96.62 | 2024 | |
| Therapeuticsmd, INC. | $95.98 | 2019-2022 | |
| Minerva Surgical, INC | $79.34 | 2019 |
Show all 43 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Coopersurgical, INC. | $75.05 | 2019-2024 | Paragard T 380a, Paragard T 380a, Wallach Cryosurgical Equipment |
| Organon LLC | $71.29 | 2022-2023 | Nexplanon |
| Myovant Sciences INC. | $66.10 | 2022 | |
| Millicent US INC | $47.61 | 2023-2024 | Intrarosa |
| Intuitive Surgical, INC. | $46.48 | 2022 | |
| Monaghan Medical Corporation | $46.24 | 2023-2024 | Aeroeclipse, Aerochamber |
| Mylan Pharmaceuticals INC. | $45.88 | 2022 | |
| Axonics, INC. | $42.54 | 2023-2024 | Axonics |
| Exeltis, USA INC. | $35.97 | 2019-2023 | Slynd |
| Shield Therapeutics INC | $32.37 | 2023-2024 | Accrufer |
| Daiichi Sankyo INC. | $30.85 | 2019 | |
| Mission Pharmacal Company | $29.62 | 2019 | |
| Meditrina | $29.54 | 2024 | |
| Urovant Sciences INC | $25.80 | 2022 | |
| Ethicon US, LLC | $25.32 | 2025 | Echelon Flex |
| Supernus Pharmaceuticals, INC. | $20.63 | 2025 | Qelbree |
| Vertical Pharmaceuticals, LLC | $19.23 | 2019 | |
| Novo Nordisk INC | $18.98 | 2023 | Wegovy |
| Merck Sharp & Dohme LLC | $18.01 | 2020 | |
| Ascend Therapeutics US, LLC | $18.00 | 2021 | |
| Northgate Technologies, INC. | $17.95 | 2024 | Stimsite |
| Exact Sciences Corporation | $17.70 | 2023 | Cologuard Collection Kit |
| Avion Pharmaceuticals | $14.53 | 2022 | |
| Lupin INC. | $14.27 | 2019 | |
| Evofem Biosciences, INC. | $14.23 | 2022 | |
| Duchesnay USA Incorporated | $13.86 | 2019 | |
| Coloplast Corp | $13.67 | 2019 | |
| Allergan, INC. | $11.38 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ralph Garrard listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.